-
#SvjetskiDanRaka možda je završio, ali#NemaPredaha dok inovativnim metodama liječenja ne pobijedimo rak na dobrobit svih oboljelih!#Cancer#Rak#NemaPredaha#WeWontRest#EUCancerPlan#EUCancerReport#NPPRpic.twitter.com/jMdBAbV2OI -
#EUCancerReport zeigt: Große Fortschritte im Kampf gegen#Krebs - aber auch rund 50% mehr Erkrankungen als vor 25 Jahren. Krebs geht uns alle an. Und Krebs lässt sich nur besiegen, wenn wir gemeinsam all unsere Möglichkeiten in#Forschung und Versorgung nutzen.#Weltkrebstagpic.twitter.com/AujSztnu84 -
Millions of people wouldn't be here today if it wasn't for life-changing science. New treatments are helping cancer patients live life to the full after treatment & enjoy life’s simple moments
#WeWontRest#EUCancerPlan#EUCancerReport https://bit.ly/2tJWRxr pic.twitter.com/LaIP7YPTsZ -
Znanstveni napredak je besmislen ako ne dolazi do onih kojima život ovisi o tome. Predano radimo sa svim dionicima kako bismo nadišli barijere koje utječu na dostupnost pravovremene i suvremene skrbi bolesnicima. https://bit.ly/2tJWRxr
#Rak#EUCancerPlan#EUCancerReport#NPPRpic.twitter.com/XM4NQRr9i5
-
The number of potential years of working life lost due to cancer in Europe has decreased since 1995.
#WeWontRest until everyone in Europe who is touched by cancer, can look forward with hope and optimism#EUCancerPlan#EUCancerReport https://bit.ly/2tJWRxr pic.twitter.com/3NYgtMiv9c
-
Significant variance in patient outcomes occurs across Europe: more needs to be done to ensure equity of access to treatment for patients across Europe
#WeWontRest#EUCancerPlan#EUCancerReport https://bit.ly/2tJWRxr pic.twitter.com/76Q9WiKF7S
-
Spending on cancer has doubled since the mid-90s driven by demographic changes & improvements in cancer care. However, its overall share of the total health budget has remained stable over the past 20 years
#WeWontRest#EUCancerPlan#EUCancerReport https://bit.ly/2tJWRxr pic.twitter.com/8w2AGcctJP
-
Cancer mortality in children has decreased by 50% since 1995.
#WeWontRest driving innovation to help children stay healthy, so they can play, go to school and live their childhood to the fullest#EUCancerPlan#EUCancerReport https://bit.ly/2UaLmtp pic.twitter.com/ETIk7S3Fxg
-
Scientific advances are meaningless if they don’t reach the patients who need them. We are working with stakeholders to overcome barriers that could prevent patient access
#WeWontRest#EUCancerPlan#EUCancerReport https://bit.ly/2UaLmtp pic.twitter.com/TrZ8bFQppo
-
Not every patient in Europe benefits in the same way. Europe needs to put greater focus on cancer to drive change towards better outcomes in cancer for citizens and patients
#WeWontRest#EUCancerPlan#EUCancerReport https://bit.ly/2tJWRxr pic.twitter.com/RMIzSjAKMS
-
13,296 more lung cancer patients are alive for at least 5 years following a diagnosis in 2014, compared to those diagnosed in 2004.
#WeWontRest as we continue to invest in R&D to beat cancer#EUCancerPlan#EUCancerReport https://bit.ly/2tJWRxr pic.twitter.com/eq5p6IeMDD
-
Tackling cancer: what would you hope to achieve in 5 years? - Decreased mortality rates in all European countries - Improved quality of life for people living with cancer Antonella Cardone
@cancereu#EUCancerPlan#EUCancerReport pic.twitter.com/7ymtf92eeO
-
Tackling cancer: What would you hope to achieve in 5 years? Cohesion and a more collaborative approach towards our shared goal of improving patients' lives, says Alexander Roediger
@MSDInvents#EUCancerPlan#EUCancerReport pic.twitter.com/lWikOExISk
-
Martin Seychell
@EU_Health: The main problem is inequality. But inequalities mean that some countries are doing better than others. We should identify best practices to bring everyone to the highest level#EUCancerReport#EUCancerPlanpic.twitter.com/rsowDEuPPF
-
Martin Seychell
@EU_Health - we must look at both prevention, early detection, access to treatment and societal issues. Inequalities is high on the agenda, and better use of data. We need to move to an outcomes-based approach.#EUCancerReport@EFPIApic.twitter.com/JgUgEKU3Xp
-
In some countries, only 20% of approved medicines are available to patients. More needs to be done to ensure equity of access to treatment for patients across Europe, says Alexander Roediger
@MSDInvents#EUCancerPlan#EUCancerReport https://bit.ly/2tJWRxr pic.twitter.com/j5gqpeLwH7
-
The pharmaceutical industry invested €8.5 billion into cancer research in 2015, leading to an increase in the number of cancer medicines and indications over recent years
#EUCancerReport
https://bit.ly/38P1K73
#EUCancerPlanpic.twitter.com/UYrxg7VegK
-
The pharmaceutical industry is driving increased R&D in oncology, leading to more treatments becoming available
#EUCancerReport@EFPIApic.twitter.com/IKwrhHappH
-
All countries spend between 4-7% of total health expenditure on cancer care Link to the
#EUCancerReport
https://bit.ly/38P1K73
#EUCancerPlanpic.twitter.com/6gpYIIrKnU
-
Cancer mortality going up overall due to ageing population, but decreasing strongly in younger populations
#EUCancerReport@EFPIApic.twitter.com/OqVxAa6VS9
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.